WallStreetZenWallStreetZen

NASDAQ: NPCE
Neuropace Inc Stock Ownership - Who owns Neuropace?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Neuropace Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Martha MorrellCHIEF MEDICAL OFFICER2025-08-203,052$8.66
$26.43kSell
URI GeigerDirector2025-06-211,140$10.41
$11.87kBuy
Rakhi KumarDirector2025-06-211,440$10.41
$14.99kBuy
Joseph LacobDirector2025-06-211,080$10.41
$11.24kBuy
Frank M. FischerDirector2025-06-212,281$10.41
$23.75kBuy
Martha MorrellCHIEF MEDICAL OFFICER2025-06-031,338$13.54
$18.12kSell
Rebecca KuhnCHIEF FINANCIAL OFFICER2025-06-031,337$13.54
$18.10kSell
Martha MorrellCHIEF MEDICAL OFFICER2025-05-27357$12.66
$4.52kSell
Rebecca KuhnCHIEF FINANCIAL OFFICER2025-05-27357$12.66
$4.52kSell
Joel BeckerCHIEF EXECUTIVE OFFICER2025-05-271,126$12.66
$14.26kSell

1 of 8

NPCE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NPCE insiders and whales buy or sell their stock.

NPCE Shareholders

What type of owners hold Neuropace Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
URI Geiger26.84%8,877,932$79.81MInsider
Greg Shaw Garfield17.09%5,653,237$50.82MInsider
Accelmed Partners II LP13.40%4,432,948$39.85MInsider
Evan Norton12.22%4,042,657$36.34MInsider
Orbimed Advisors LLC10.50%3,473,199$31.22MInsider
Orbimed Advisors LLC7.90%2,614,184$23.50MInstitution
Morgan Stanley7.81%2,585,073$23.24MInstitution
Blackrock Inc7.01%2,319,166$20.85MInstitution
Soleus Capital Management LP6.99%2,312,957$20.79MInstitution
First Light Asset Management LLC4.17%1,380,410$12.41MInstitution

1 of 3

NPCE vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NPCE44.29%55.71%Net SellingNet Selling
BWAY15.30%0.00%
TCMD76.35%23.65%Net SellingNet Selling
VMD61.79%13.25%Net SellingNet Selling
CLPT32.20%26.46%Net SellingNet Selling
View Top Medical Device Stocks

Neuropace Stock Ownership FAQ

Who owns Neuropace?

Neuropace (NASDAQ: NPCE) is owned by 68.03% institutional shareholders, 85.57% Neuropace insiders, and 0.00% retail investors. URI Geiger is the largest individual Neuropace shareholder, owning 8.88M shares representing 26.84% of the company. URI Geiger's Neuropace shares are currently valued at $76.79M.

If you're new to stock investing, here's how to buy Neuropace stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.